Which medication should the nurse question in an older adult client with Parkinson's disease?

In the context of managing Parkinson's disease in older adult clients, it is important to carefully consider the side effects and interactions of various medications. Benztropine, an anticholinergic medication, is used to manage extrapyramidal symptoms associated with the condition. However, it can cause cognitive impairment, confusion, and worsen memory issues, particularly in older adults, who may already be at higher risk for these side effects due to age-related changes in the central nervous system.

In older patients, the use of anticholinergic medications like benztropine should be approached with caution, as they may lead to an increase in anticholinergic burden, which can have deleterious effects such as worsening dementia symptoms or exacerbating confusion. Therefore, questioning the use of benztropine for an older adult with Parkinson's disease is prudent and reflects a careful consideration of both the benefits and potential risks.

On the other hand, docusate is a stool softener that does not pose similar risks related to cognitive side effects. Amantadine offers benefits in managing Parkinson’s symptoms and may actually help with dyskinesia in some patients. Levodopa-carbidopa is the cornerstone of treatment for Parkinson’s disease and is typically the